sluit venster

Log in

Gebruikersnaam Wachtwoord Gebruikersnaam en/of wachtwoord vergeten? Gebruikersnaam en wachtwoord aanvragen

Zoek in de HOVON website

Let op!
Mogelijk ziet u niet alle beschikbare info op deze pagina, omdat u niet bent ingelogd, of omdat u niet de juiste privileges heeft.

Clinical picture: MH (Morbus Hodgkin)

Trial: HOVON-associated HD21


News
1. Overview
Study details
2. Patient eligibility criteria
3. Registration (& randomization) of patients
4. Participating parties
5. Participating sites
6. Instruction videos
7. Download documentation / forms


return to top

News


No news


1. Overview



Summary

HD 21 – Treatment optimization trial in the first line treatment of adv stage HL: comparison of 4-6 cycles of esc BEACOPP with 4-6 cycles of BrECADD


Status

open


Members

A-UMC loc VUmc- JM Zijlstra
MeanderMC – JC Regelink
Jeroen Bosch ziekenhuis- H Pruijt
ADR ziekenhuis Goes- S Kuipers
OLVG A’dam – A. Gerrits
WFG Hoorn- C Klerk
Haga ziekenhuis- L Bohmer
LUMC- H Veelken
Anthonius ziekenhuis- M Sohne



Study details



Type of study

Prospective randomized Phase III study


Echelon level

Limited site selection


Echelon level specification

See participating hospital members


Type of monitoring for this study

Site evaluation visits


Target number of patients

1500


Date of activation

21-Dec-2017


Approved by

VUmc
Eudract-nr: 2014-005130-55


Change history / amendement

Protocol _V 6.0_final_2018-05-23


Study objectives

Progression free survival
Treatment related morbidity


2. Patient eligibility criteria



Inclusion criteria

Classical Hodgkin lymphoma
Stage IIB with large mediastinal mass and/or extranodal disease
Stage III-IV
Age 18-60 yrs
Written informed consent
Normal organ function


Exclusion criteria

Chemotherapy or radiotherapy in medical history
Malignant disease within the last 5 yrs
Prior or concurrent disease that prevents treatment according to protocol
Incomplete diagnosis of the disease stage


3. Registration (& randomization) of patients



Registration

Via eCRF
Contact Mrs Ines Versteegden (c.versteegden@vumc.nl) for further details
020-4442258


4. Participating parties



5. Participating sites



6. Instruction videos



7. Download documentation / forms


 Protocol



return to top